TrialInternational journal of clinical oncology2017

A phase II study of 5-fluorouracil/L-leucovorin/oxaliplatin (mFOLFOX6) in Japanese patients with metastatic or unresectable small bowel adenocarcinoma.

Takahiro Horimatsu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.